Security key
92790C104
Viridian Therapeutics, Inc.\DE - Common Stock (VRDN)
CUSIP: 92790C104
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 101,911,273
- Total 13F shares
- 41,109,026
- Share change
- +2,875,727
- Total reported value
- $1,200,793,517
- Put/Call ratio
- 111%
- Price per share
- $29.21
- Number of holders
- 122
- Value change
- +$91,003,851
- Number of buys
- 80
- Number of sells
- 39
Report period
Q4 2022
Institutions
122
Top holders
10
VRDN full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Viridian Therapeutics, Inc.\DE SEC filings
Viridian Therapeutics, Inc.\DE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92790C104
Recent filing periods:
Top shareholders of VRDN - Viridian Therapeutics, Inc.\DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Commodore Capital LP |
13F
|
Company |
2.6%
|
2,696,340
|
$55,302,000 | — | 30 Sep 2022 | |
| VR Adviser, LLC |
13F
|
Company |
2.1%
|
2,130,308
|
$43,693,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.9%
|
1,982,062
|
$40,653,000 | — | 30 Sep 2022 | |
| Deep Track Capital, LP |
13F
|
Company |
1.9%
|
1,970,290
|
$40,411,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
1,856,800
|
$38,083,000 | — | 30 Sep 2022 | |
| BVF INC/IL |
13F
|
Company |
1.7%
|
1,741,840
|
$35,725,000 | — | 30 Sep 2022 | |
| Vivo Capital, LLC |
13F
|
Company |
1.6%
|
1,660,019
|
$34,047,000 | — | 30 Sep 2022 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
1.6%
|
1,636,211
|
$33,559,000 | — | 30 Sep 2022 | |
| Frazier Life Sciences Public Fund, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,505,200
|
$31,609,200 | — | 23 Sep 2021 | |
| Fairmount Funds Management LLC |
13F
|
Company |
1.3%
|
1,369,623
|
$28,091,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.3%
|
1,360,612
|
$27,906,000 | — | 30 Sep 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.3%
|
1,310,000
|
$26,868,000 | — | 30 Sep 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
1,220,575
|
$25,034,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
1,178,549
|
$24,172,000 | — | 30 Sep 2022 | |
| TCG Crossover Management, LLC |
13F
|
Company |
1.1%
|
1,164,000
|
$23,874,000 | — | 30 Sep 2022 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.98%
|
1,000,000
|
$20,510,000 | — | 30 Sep 2022 | |
| Logos Global Management LP |
13F
|
Company |
0.98%
|
1,000,000
|
$20,510,000 | — | 30 Sep 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.87%
|
882,925
|
$18,109,000 | — | 30 Sep 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.86%
|
880,000
|
$18,049,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.75%
|
762,060
|
$15,630,000 | — | 30 Sep 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.64%
|
653,751
|
$13,409,000 | — | 30 Sep 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.62%
|
628,275
|
$12,886,000 | — | 30 Sep 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.6%
|
608,662
|
$12,483,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.59%
|
599,766
|
$12,301,000 | — | 30 Sep 2022 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.52%
|
535,000
|
$10,973,000 | — | 30 Sep 2022 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.48%
|
484,891
|
$9,945,000 | — | 30 Sep 2022 | |
| Eversept Partners, LP |
13F
|
Company |
0.47%
|
478,387
|
$9,811,717 | — | 30 Sep 2022 | |
| Yiheng Capital Management, L.P. |
13F
|
Company |
0.37%
|
373,051
|
$7,651,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
369,728
|
$7,583,000 | — | 30 Sep 2022 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.36%
|
362,735
|
$7,440,000 | — | 30 Sep 2022 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.33%
|
336,790
|
$6,908,000 | — | 30 Sep 2022 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.3%
|
310,800
|
$6,375,000 | — | 30 Sep 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.29%
|
295,874
|
$6,068,000 | — | 30 Sep 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.28%
|
286,707
|
$5,880,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.27%
|
272,811
|
$5,595,000 | — | 30 Sep 2022 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
261,083
|
$5,355,000 | — | 30 Sep 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.22%
|
224,316
|
$4,601,000 | — | 30 Sep 2022 | |
| Atlas Venture Advisors, Inc. |
13F
|
Company |
0.21%
|
209,505
|
$4,297,000 | — | 30 Sep 2022 | |
| Walleye Capital LLC |
13F
|
Company |
0.19%
|
189,529
|
$3,887,000 | — | 30 Sep 2022 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.17%
|
169,529
|
$3,477,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
164,750
|
$3,379,000 | — | 30 Sep 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.11%
|
108,968
|
$2,235,000 | — | 30 Sep 2022 | |
| HighVista Strategies LLC |
13F
|
Company |
0.1%
|
102,372
|
$2,100,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
101,600
|
$2,084,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.1%
|
102,749
|
$2,049,000 | — | 30 Sep 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.09%
|
95,775
|
$1,964,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
90,263
|
$1,851,000 | — | 30 Sep 2022 | |
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
0.09%
|
90,072
|
$1,847,000 | — | 30 Sep 2022 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.08%
|
81,870
|
$1,679,000 | — | 30 Sep 2022 | |
| Global IMC LLC |
13F
|
Company |
0.08%
|
78,810
|
$1,616,000 | — | 30 Sep 2022 |
Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock (VRDN) as of Q4 2022
As of 31 Dec 2022,
Viridian Therapeutics, Inc.\DE - Common Stock (VRDN) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,109,026 shares.
The largest 10 holders included
BlackRock Inc., VR Adviser, LLC, VANGUARD GROUP INC, COMMODORE CAPITAL LP, STATE STREET CORP, Deep Track Capital, LP, Paradigm Biocapital Advisors LP, Vivo Capital, LLC, Fairmount Funds Management LLC, and BVF INC/IL.
This page lists
122
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
104
Q4 2022 holders
122
Holder diff
18
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.